NCT06721494View on ClinicalTrials.gov

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

January 6, 2026

Study Completion Date

February 6, 2026

Conditions
Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse
Interventions
DRUG

Methamphetamine

Methamphetamine HCl for intravenous administration

DRUG

Sterile Saline

Sterile Saline for intravenous administration

DRUG

CS-1103

CS-1103 for intravenous administration

Trial Locations (1)

91206

California Clinical Trials Medical Group, Glendale

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Clear Scientific, Inc.

INDUSTRY

NCT06721494 - A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine | Biotech Hunter | Biotech Hunter